Novel Treatment Makes Pancreatic Cancer Susceptible to Immunotherapy, Mouse Study Shows Pancreatic cancer is one of the most aggressive and deadly tumor types and notorious for its resistance to virtually all types of treatment, including newer immunotherapies. Read more...
FDA Approves Second CAR-T Cancer Therapy to Treat Multiple Myeloma, Opening the Door for Greater Access The Food and Drug Administration on Monday approved a new CAR-T therapy for multiple myeloma, a move that could ease strain on limited supplies of potentially lifesaving cancer therapies. Read more...
Researchers Label Early CAR-T Therapy Patient ‘Cured’ After Living a Decade Without Cancer In 2010, Doug Olson became the second person in the world to receive CAR-T cell therapy, an experimental tactic to engineer his own immune cells to fight cancer. His doctors had tempered expectations for how well it
Biden Relaunches 'Cancer Moonshot' Initiative Aimed at Halving Rate of Cancer Deaths by 2047 President Joe Biden on Wednesday relaunched the White House's "Cancer Moonshot" initiative, committing the nation to working toward reducing the death rate from cancer by at least 50% over the next 25 years. Read more...
New Treatment Target ID’d for Radiation-Resistant Cervical Cancer Understanding how cells die is key to developing new treatments for many diseases, whether the goal is to make cancer cells die or keep healthy cells alive in the face of other illnesses, such as massive infections or strokes. Two new studies
Improving Drug Options for Colorectal Cancer Patients Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. But some patients are not eligible for these treatments because they have cancer-promoting mutations
Antipsychotic Drugs May Increase Risk of Breast Cancer Tracking medications provided to over a half million U.S. women, researchers at Washington University School of Medicine in St. Louis have found that many commonly prescribed older antipsychotic medications, and some newer ones, are associated with a significant increase in risk of
New Technique May Lead to Safer Stem Cell Transplants For hard-to-treat leukemias, lymphomas and other blood cancers, stem cell transplantation is the gold standard of care. The procedure involves replacing a patient’s own blood-forming stem cells with a donor’s stem cells and, in the process, eradicating cancer cells in the
Cancer Moonshot Grant Funds Research Into Reducing Health Disparities Washington University School of Medicine in St. Louis has received a $17 million grant from the National Institutes of Health (NIH) to address disparities in cancer research, treatment and outcomes in underrepresented populations. The research, funded through the National Cancer Institute’s
Turning CAR-T Tech Against Solid Tumors by Targeting Protein Fragments in Cancer Cells CAR-T therapies, which arm a patient’s own immune cells with cancer-fighting proteins, are currently used to treat some patients with blood cancers. But the technology has been hard to apply to other cancers, partly because of a